AACC welcomed thousands of medical professionals and healthcare leaders to the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo from July 24-28.
The meeting featured groundbreaking diagnostic advances that will solve challenging patient health problems, and affirmed just how essential laboratory medicine professionals are to patient safety and care.
As of Wednesday, July 27, nearly 17,000 laboratory medicine professionals had registered for the meeting—a clear sign that meeting attendance has bounced back to pre-pandemic levels. More attendees are expected today, the last day of the meeting.
A major highlight of the conference program was an in-depth discussion with Theranos whistleblowers Erika Cheung and Tyler Shultz about their efforts to reveal Theranos’ fraud and protect patients. The session offered a vivid lesson in the standards of ethics and accountability at work within the profession.
Attendees also had the chance to see five plenary talks presented by life sciences pioneers.
In the opening keynote, Dr. Lucila Ohno-Machado discussed performance measures that may help clinicians select precision medicine artificial intelligence models for routine use.
Monday’s plenary speaker, Dr. George Church—winner of AACC’s 2022 Wallace H. Coulter Lectureship Award—focused on combining machine learning with multiplexing and how this is the key to unlocking the treasure chest of genomic technologies.
In Tuesday’s plenary, Dr. Alysson Muotri explored brain organoids, which have been used to model the neurotropic effects of SARS-CoV-2 and provide insight into organogenesis and neurotoxicology.
On Wednesday, Dr. Thomas Lee described a three-component model for building trust between patients and the healthcare workforce.
In the closing keynote, Dr. Livia Schiavinato Eberlin presented on the development and application of direct mass spectrometry techniques used in clinical microbiology labs, clinical pathology labs, and the operating room.
As part of AACC’s Disruptive Technology Award competition, biotech innovators presented novel technologies that could help more patients get accurate diagnoses. Nanopath won with its solid-state biosensing platform, which provides clinically actionable genetic information in less than 15 minutes and could greatly improve routine women’s health screening at the point of care.
The 2022 AACC Clinical Lab Expo also featured 781 exhibitors and covered 246,700 net square feet. This dynamic exhibit featured cutting-edge tests from all laboratory medicine disciplines, including COVID-19 testing, artificial intelligence, mobile health, molecular diagnostics, mass spectrometry, point of care, and automation.
The 2023 AACC Annual Scientific Meeting & Clinical Lab Expo will be held in Anaheim, California from July 23-27, 2023.